hematologic malignancies

Learn about new developments in next generation molecular sequencing tests at the DUHS Clinical Labs' Clinical Molecular Diagnostics Laboratory.

Leukemia survivor and Duke Heart NP Dayana Ramos will hold a Be The Match drive at Duke University Hospital on June 24

DCI member and physician-scientist Sandeep Dave, MD, MS, has been named the Wellcome Clinical Distinguished Professor of Medicine.

Looking for a great read on how to develop, integrate, & implement a comprehensive cancer center? A new open-access book co-authored by Nelson Chao, MD, MBA, is now available.

Join faculty speakers from the DCI Hematologic Malignancies & Cellular Therapy Disease Group on Oct. 5 for a virtual OncLive summit on leukemia & lymphoma.

The new Duke Blood Cancer Center opens up the opportunity to transition some cancer treatments from the inpatient to the outpatient setting and the infusion room is open every day.

For most cancers, advances in genomics haven't changed cancer diagnosis and treatment very much. Sandeep Dave, MD, MS, envisions a way to change that.

Research study participants encouraged Jessica Jin to pursue a career in nursing. After four years providing care to oncology patients at Duke, she’s won a national award.

DCI faculty Thomas Leblanc, MD, MA, MHS, FAAHPM, has been named a Fellow of the American Society of Clinical Oncology.

The Duke Cancer Institute Virtual Grand Rounds Series, came to a successful summer close with its final session on June 19.

Lifetime Achievement Award Winner Keith Sullivan, MD, and colleagues reflect on his career and passion.

Lawrence A. David, PhD, and Anthony D. Sung, MD, named recipients of the Damon Runyon-Rachleff Innovation Award for project to personalize pre-biotic treatments for HCT patients.

Medical oncologist Edwin P. Alyea, III, MD, formerly with Dana-Farber Cancer Institute, has been named chief medical officer (CMO) for Duke Cancer Institute.

ICYMI the AACI's Physician Clinical Leadership Initiative (PCLI) presented a two-part webinar series on hereditary cancer programs and cancer risk assessment.

Duke Cancer Institute hematologic oncologist Joseph Moore, MD, after 44 years, retired from clinical practice this summer. He and colleagues reflect on his legacy.

The Division of Cellular Therapy will host an indoor yard sale at St. Luke’s Episcopal Church on Saturday, Aug. 17, from 8 a.m. to 1 p.m.

DCI blood cancer researchers shared new scientific discoveries and treatments in lymphomas, leukemias, and multiple myeloma at OncLive summit.

After college graduation, Shannon Voelkel started her “dream job” working for a well-known interior design firm. A year-and-a-half later, she learned life had other plans.